Literature DB >> 12196474

Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy.

Yuji Hiramatsu1, Naotaka Sekiguchi, Michio Hayashi, Keiji Isshiki, Tamotsu Yokota, George L King, Mary R Loeken.   

Abstract

Activation of the diacylglycerol-protein kinase C (DAG-PKC) cascade by excess glucose has been implicated in vascular complications of diabetes. Its involvement in diabetic embryopathy has not been established. We examined DAG production and PKC activities in embryos and decidua of streptozotocin (STZ)-diabetic or transiently hyperglycemic mice during neural tube formation. STZ diabetes significantly increased DAG and total PKC activity in decidua (1.5- and 1.4-fold, respectively) and embryos (1.7- and 1.3-fold, respectively) on day 9.5. Membrane-associated PKC alpha, betaII, delta, and zeta were increased in decidua by 1.25- to 2.8-fold. Maternal hyperglycemia induced by glucose injection on day 7.5, the day before the onset of neural tube formation, also increased DAG, PKC activity, and PKC isoforms (1.1-, 1.6-, and 1.5-fold, respectively) in the embryo on day 9.5. Notably, membrane-associated PKC activity was increased 24-fold in embryos of diabetic mice with structural defects. These data indicate that hyperglycemia just before organogenesis activates the DAG-PKC cascade and is correlated with congenital defects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196474     DOI: 10.2337/diabetes.51.9.2804

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

Review 1.  Oxidative stress, unfolded protein response, and apoptosis in developmental toxicity.

Authors:  Allison Kupsco; Daniel Schlenk
Journal:  Int Rev Cell Mol Biol       Date:  2015-03-11       Impact factor: 6.813

2.  High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells.

Authors:  J Fu; S S W Tay; E A Ling; S T Dheen
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

3.  Maternal diet modulates the risk for neural tube defects in a mouse model of diabetic pregnancy.

Authors:  Claudia Kappen; Claudia Kruger; Jacalyn MacGowan; J Michael Salbaum
Journal:  Reprod Toxicol       Date:  2010-09-22       Impact factor: 3.143

4.  Protein kinase Cβ2 inhibition reduces hyperglycemia-induced neural tube defects through suppression of a caspase 8-triggered apoptotic pathway.

Authors:  Yuanning Cao; Zhiyong Zhao; Richard L Eckert; E Albert Reece
Journal:  Am J Obstet Gynecol       Date:  2011-03       Impact factor: 8.661

Review 5.  Genetic, epigenetic, and environmental contributions to neural tube closure.

Authors:  Jonathan J Wilde; Juliette R Petersen; Lee Niswander
Journal:  Annu Rev Genet       Date:  2014-10-06       Impact factor: 16.830

6.  The essential role of protein kinase Cδ in diabetes-induced neural tube defects.

Authors:  Yuanning Cao; Zhiyong Zhao; Richard L Eckert; E Albert Reece
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-21

Review 7.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

Review 8.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

9.  Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes.

Authors:  Y Sugimura; T Murase; K Oyama; A Uchida; N Sato; S Hayasaka; Y Kano; Y Takagishi; Y Hayashi; Y Oiso; Y Murata
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

10.  Role of impaired endothelial cell Ca(2+) signaling in uteroplacental vascular dysfunction during diabetic rat pregnancy.

Authors:  Natalia I Gokina; Adrian D Bonev; Alexander P Gokin; Gabriela Goloman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.